Bio-Techne (TECH) Short term Debt (2016 - 2023)
Bio-Techne's (TECH) quarterly Short term Debt came in at $1.8 million in Q3 2023, down 76.35% year-on-year from $7.4 million in Q3 2022, and down 50.0% quarter-over-quarter from $3.5 million in Q2 2023.
Bio-Techne (TECH) Short term Debt (2016 - 2023) Analysis & Trends
Bio-Techne's Short term Debt history runs 8 years deep, the most recent figure standing at $1.8 million for Q3 2023.
- On a quarterly basis, Short term Debt fell 76.35% year-over-year to $1.8 million in Q3 2023; TTM through Sep 2023 was $1.8 million, a 76.35% decrease from a year earlier, with the FY2023 full-year figure at $3.5 million, down 72.0% from the prior year.
- Short term Debt retreated to $1.8 million in Q3 2023 per TECH's latest filing, from $3.5 million in the prior quarter.
- Across five years, Short term Debt topped out at $12.5 million in Q3 2019 and bottomed at $1.8 million in Q3 2023.
- The 5-year median for Short term Debt is $5.6 million (2020), against an average of $7.5 million.
- Across the five-year window, Short term Debt surged 267.65% in 2020 and plunged 76.35% in 2023, its largest moves.
- Year by year, Short term Debt stood at $12.5 million in 2019, then plunged by 60.14% to $5.0 million in 2020, then slumped by 59.86% to $2.0 million in 2021, then soared by 270.0% to $7.4 million in 2022, then plunged by 76.35% to $1.8 million in 2023.
- Per Business Quant, the three latest TECH Short term Debt figures stand at $1.8 million (Q3 2023), $3.5 million (Q2 2023), and $5.2 million (Q1 2023).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Bio-Techne | 11.23 Bn | 11.02 Bn | 208.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 1.75 Mn |
| Jun 30, 2023 | 3.50 Mn |
| Mar 31, 2023 | 5.25 Mn |
| Sep 30, 2022 | 7.40 Mn |
| Jun 30, 2022 | 12.50 Mn |
| Mar 31, 2022 | 12.50 Mn |
| Dec 31, 2021 | 2.00 Mn |
| Sep 30, 2021 | 5.00 Mn |
| Jun 30, 2021 | 4.00 Mn |
| Mar 31, 2021 | 12.50 Mn |
| Dec 31, 2020 | 4.98 Mn |
| Sep 30, 2020 | 12.50 Mn |
| Jun 30, 2020 | 5.94 Mn |
| Mar 31, 2020 | 12.50 Mn |
| Dec 31, 2019 | 12.50 Mn |
| Sep 30, 2019 | 12.50 Mn |
| Jun 30, 2019 | 3.40 Mn |
| Mar 31, 2019 | 3.40 Mn |
| Dec 31, 2018 | 12.50 Mn |
| Sep 30, 2018 | 12.50 Mn |